Comprehensive Guide to Candidiasis Cases in Singapore
Candidiasis is a fungal infection caused by yeasts belonging to the Candida genus. Although it is often thought of as a minor nuisance, such as oral thrush or vaginal yeast infections, certain strains have become significant public health concerns worldwide.
Singapore, like many countries, has been grappling with a rising number of infections involving Candida auris, a multidrug-resistant strain.
Read on as we provide a detailed overview of candidiasis in Singapore, focusing on infection trends, clinical challenges, prevention strategies, and the country’s response to this evolving threat.
What is candidiasis?
Candidiasis refers to infections resulting from an overgrowth of Candida species, fungi that naturally reside in many parts of the human body such as the mouth, digestive tract, and genital area. Under normal conditions, the body’s immune system and competing microorganisms keep Candida in check. However, disruptions such as antibiotic use, illness, or immune suppression can trigger uncontrolled growth.
Candidiasis manifests in several forms:
- Superficial infections, including oral thrush, characterised by creamy white patches inside the mouth, and vaginal yeast infections, often causing itching, vaginal discharge, and discomfort.
- Invasive candidiasis, a far more serious condition, occurs when the fungus enters the bloodstream and spreads to vital organs like the heart, kidneys, and brain. This systemic infection can be life-threatening, particularly for hospitalised or immunocompromised patients.
Emergence of Candida auris in Singapore
Among Candida species, Candida auris has drawn intense global attention for its unique challenges. First identified in 2009, C. auris has quickly become notorious for its multidrug resistance, persistence in healthcare environments, and ability to cause outbreaks.
Singapore’s Ministry of Health reported 38 cases of C. auris infection between January 2019 and March 2023, including two deaths attributed to the fungus, according to CNA. The initial cases date back to 2012, with at least three infections confirmed between 2012 and 2021, according to The Straits Times. The relatively low case numbers to date should not mask the potential threat it poses given its rapid global spread.
C. auris is primarily found in healthcare facilities where it colonises patients with weakened immune systems. Its ability to survive on surfaces for extended periods contributes to outbreaks within hospitals and nursing homes. The fungus is often resistant to multiple antifungal drugs, complicating treatment options and increasing risks of severe outcomes.
Clinical implications and treatment challenges
Infections caused by C. auris are often difficult to diagnose and treat. Symptoms vary widely, from fever and chills in bloodstream infections to localised pain or inflammation in urinary tract or wound infections. Delays in diagnosis can occur because standard laboratory methods sometimes misidentify C. auris as other Candida species, necessitating the use of molecular testing and specialised culture techniques.
Treatment is complicated by the fungus’s frequent resistance to first-line antifungals. Research shows that over 90% of C. auris isolates resist fluconazole, a common antifungal, and many are also resistant to amphotericin B and echinocandins—the latter two being critical alternatives in antifungal therapy, according to researchers from NUS Medicine. This multidrug resistance limits therapeutic options and increases the likelihood of treatment failure.
Because of these challenges, management often requires combination antifungal therapies, longer hospital stays, and close monitoring, placing additional burdens on patients and healthcare resources.
Recent research and discoveries
Singaporean scientists from the National University of Singapore, Singapore General Hospital, and A*STAR’s Genome Institute have made notable progress in understanding C. auris. They recently identified a new C. auris clade—bringing the total known clades worldwide to six, which highlights the fungus’s evolving genetic diversity, according to NUS Medicine.
This discovery is significant because it can help trace transmission patterns and reveal how different strains respond to antifungal treatments. The researchers are also developing machine learning models to detect new clades early, enabling faster responses to emerging strains and potentially preventing widespread outbreaks.
Infection control strategies in healthcare settings
Singapore has adopted strict infection control measures to combat C. auris transmission in hospitals and care facilities. Key actions include:
- Systematic screening of patients at high risk of colonisation or infection upon admission.
- Immediate isolation of infected or colonised patients to prevent cross-transmission.
- Enhanced environmental cleaning and disinfection with agents effective against C. auris.
- Education and reinforcement of hand hygiene practices and use of personal protective equipment by healthcare workers.
In 2025, Singapore established the Communicable Diseases Agency (CDA) to integrate efforts across multiple health agencies, aiming for a more coordinated response to infectious diseases such as C. auris, according to CNA.
Prevention tips for individuals
While healthcare settings bear the brunt of managing C. auris, individuals can also take preventive measures to reduce candidiasis risk:
- Practising thorough hand hygiene, especially after hospital visits or contact with vulnerable individuals.
- Managing underlying health conditions such as diabetes and immune disorders proactively.
- Avoiding unnecessary or prolonged use of antibiotics and antifungal drugs to preserve normal microbial balance.
- Ensuring proper care and hygiene when using medical devices such as catheters.
- Seeking early medical attention for persistent symptoms like oral discomfort, unexplained fever, or unusual discharge.
Conclusion
Candidiasis remains a common fungal infection worldwide, but the emergence of multidrug-resistant Candida auris has intensified the threat landscape in Singapore. Rising case numbers, complicated treatment options, and the fungus’s persistence in healthcare environments necessitate continued vigilance.
Thanks to ongoing research, robust surveillance, and comprehensive infection control efforts, Singapore is well-prepared to tackle this challenge. For anyone concerned about candidiasis or experiencing symptoms suggestive of fungal infection, seeking timely professional care is essential.
Elyon Family Clinic & Surgery provides expert diagnosis and personalised treatment plans for candidiasis and other infectious diseases. Our dedicated team is committed to helping you maintain your health with compassionate, evidence-based care. To learn more or schedule a consultation, visit Elyon Family Clinic & Surgery.
